Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Total Non-Current Liabilities (2018 - 2026)

TELA Bio has reported Total Non-Current Liabilities over the past 8 years, most recently at $73.6 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 29.81% year-over-year to $73.6 million; the TTM value through Dec 2025 reached $73.6 million, up 29.81%, while the annual FY2025 figure was $73.6 million, 29.81% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $73.6 million at TELA Bio, up from $58.5 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $73.6 million in Q4 2025 and troughed at $36.6 million in Q1 2021.
  • A 5-year average of $52.7 million and a median of $55.3 million in 2022 define the central range for Total Non-Current Liabilities.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 35.11% in 2022 and later fell 1.32% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $42.1 million in 2021, then grew by 24.37% to $52.3 million in 2022, then increased by 9.87% to $57.5 million in 2023, then fell by 1.32% to $56.7 million in 2024, then rose by 29.81% to $73.6 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for TELA at $73.6 million in Q4 2025, $58.5 million in Q3 2025, and $57.1 million in Q2 2025.